Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19. Chen Y, Xue Y, Yang J. J Med Virol 2023 Feb 21. doi: 10.1002/jmv.28592.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen Y, Xue Y, Yang J. Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19. J Med Virol 2023 Feb 21. doi: 10.1002/jmv.28592.
PMID: 36806030